Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)
Titel:
Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)
Auteur:
Ferreira, João Pedro Cleland, John G.F. Girerd, Nicolas Pellicori, Pierpaolo Hazebroek, Mark R. Verdonschot, Job Collier, Timothy J. Petutschnigg, Johannes Clark, Andrew L. Staessen, Jan A. Heymans, Stephane Rossignol, Patrick Zannad, Faiez